Androgen receptor pathway inhibitors and taxanes in metastatic prostate cancer: an outcome-adaptive randomized platform trial (vol 30, pg 3291, 2024)
Gespeichert in:
| Veröffentlicht in: | NATURE MEDICINE 2024-08, Vol.30 (11), p.3381 |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 11 |
| container_start_page | 3381 |
| container_title | NATURE MEDICINE |
| container_volume | 30 |
| creator | De, Laere B Crippa, A Discacciati, A Larsson, B Persson, M Johansson, S D'hondt, S Bergstrom, R Chellappa, V Mayrhofer, M |
| description | |
| doi_str_mv | 10.1038/s41591-024-03268-0 |
| format | Article |
| fullrecord | <record><control><sourceid>swepub</sourceid><recordid>TN_cdi_swepub_primary_oai_swepub_ki_se_881503</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>oai_swepub_ki_se_881503</sourcerecordid><originalsourceid>FETCH-LOGICAL-s123t-758b0a6448dcace316632ad0376a5e9a7cd513225ba847e8e700a7601cc070ee3</originalsourceid><addsrcrecordid>eNotjs1OwzAQhHMAiVJ4AU57BKmGdZwfh1tV8SdV4gLnaOtsW0MTR7bbUt6D9yWInmb0aWY0SXIl8Vai0nchk3klBaaZQJUWWuBJMpJYaqGrvDhLzkP4QESFeTVKfqZd492KO_BsuI_OQ09xvacD2G5tF3YgAahrINIXdRwGDC1HCpGiNdB79-cYDHWG_f0QBbeNxrUsqKE-2h2DH_qutd_cQL-huHS-hegtbeB65zagcAL9ClRayQmkw--bi-R0SZvAl0cdJ--PD2-zZzF_fXqZTeciyFRFUeZ6gVRkmW4MGVayKFRKDaqyoJwrKk2TS5Wm-YJ0VrLmEpHKAqUxWCKzGififzfsud8u6t7blvyhdmTrI_ocHNdayxyV-gUV_mvi</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Androgen receptor pathway inhibitors and taxanes in metastatic prostate cancer: an outcome-adaptive randomized platform trial (vol 30, pg 3291, 2024)</title><source>Springer Nature - Complete Springer Journals</source><source>Nature</source><source>SWEPUB Freely available online</source><creator>De, Laere B ; Crippa, A ; Discacciati, A ; Larsson, B ; Persson, M ; Johansson, S ; D'hondt, S ; Bergstrom, R ; Chellappa, V ; Mayrhofer, M</creator><creatorcontrib>De, Laere B ; Crippa, A ; Discacciati, A ; Larsson, B ; Persson, M ; Johansson, S ; D'hondt, S ; Bergstrom, R ; Chellappa, V ; Mayrhofer, M</creatorcontrib><identifier>ISSN: 1078-8956</identifier><identifier>DOI: 10.1038/s41591-024-03268-0</identifier><language>eng</language><ispartof>NATURE MEDICINE, 2024-08, Vol.30 (11), p.3381</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,550,776,780,881,27902</link.rule.ids><backlink>$$Uhttp://kipublications.ki.se/Default.aspx?queryparsed=id:159549197$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>De, Laere B</creatorcontrib><creatorcontrib>Crippa, A</creatorcontrib><creatorcontrib>Discacciati, A</creatorcontrib><creatorcontrib>Larsson, B</creatorcontrib><creatorcontrib>Persson, M</creatorcontrib><creatorcontrib>Johansson, S</creatorcontrib><creatorcontrib>D'hondt, S</creatorcontrib><creatorcontrib>Bergstrom, R</creatorcontrib><creatorcontrib>Chellappa, V</creatorcontrib><creatorcontrib>Mayrhofer, M</creatorcontrib><title>Androgen receptor pathway inhibitors and taxanes in metastatic prostate cancer: an outcome-adaptive randomized platform trial (vol 30, pg 3291, 2024)</title><title>NATURE MEDICINE</title><issn>1078-8956</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>D8T</sourceid><recordid>eNotjs1OwzAQhHMAiVJ4AU57BKmGdZwfh1tV8SdV4gLnaOtsW0MTR7bbUt6D9yWInmb0aWY0SXIl8Vai0nchk3klBaaZQJUWWuBJMpJYaqGrvDhLzkP4QESFeTVKfqZd492KO_BsuI_OQ09xvacD2G5tF3YgAahrINIXdRwGDC1HCpGiNdB79-cYDHWG_f0QBbeNxrUsqKE-2h2DH_qutd_cQL-huHS-hegtbeB65zagcAL9ClRayQmkw--bi-R0SZvAl0cdJ--PD2-zZzF_fXqZTeciyFRFUeZ6gVRkmW4MGVayKFRKDaqyoJwrKk2TS5Wm-YJ0VrLmEpHKAqUxWCKzGififzfsud8u6t7blvyhdmTrI_ocHNdayxyV-gUV_mvi</recordid><startdate>20240828</startdate><enddate>20240828</enddate><creator>De, Laere B</creator><creator>Crippa, A</creator><creator>Discacciati, A</creator><creator>Larsson, B</creator><creator>Persson, M</creator><creator>Johansson, S</creator><creator>D'hondt, S</creator><creator>Bergstrom, R</creator><creator>Chellappa, V</creator><creator>Mayrhofer, M</creator><scope>ADTPV</scope><scope>BZJLE</scope><scope>D8T</scope><scope>STUKM</scope></search><sort><creationdate>20240828</creationdate><title>Androgen receptor pathway inhibitors and taxanes in metastatic prostate cancer: an outcome-adaptive randomized platform trial (vol 30, pg 3291, 2024)</title><author>De, Laere B ; Crippa, A ; Discacciati, A ; Larsson, B ; Persson, M ; Johansson, S ; D'hondt, S ; Bergstrom, R ; Chellappa, V ; Mayrhofer, M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-s123t-758b0a6448dcace316632ad0376a5e9a7cd513225ba847e8e700a7601cc070ee3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>De, Laere B</creatorcontrib><creatorcontrib>Crippa, A</creatorcontrib><creatorcontrib>Discacciati, A</creatorcontrib><creatorcontrib>Larsson, B</creatorcontrib><creatorcontrib>Persson, M</creatorcontrib><creatorcontrib>Johansson, S</creatorcontrib><creatorcontrib>D'hondt, S</creatorcontrib><creatorcontrib>Bergstrom, R</creatorcontrib><creatorcontrib>Chellappa, V</creatorcontrib><creatorcontrib>Mayrhofer, M</creatorcontrib><collection>SwePub</collection><collection>SwePub Other</collection><collection>SWEPUB Freely available online</collection><collection>SwePub Other full text</collection><jtitle>NATURE MEDICINE</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>De, Laere B</au><au>Crippa, A</au><au>Discacciati, A</au><au>Larsson, B</au><au>Persson, M</au><au>Johansson, S</au><au>D'hondt, S</au><au>Bergstrom, R</au><au>Chellappa, V</au><au>Mayrhofer, M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Androgen receptor pathway inhibitors and taxanes in metastatic prostate cancer: an outcome-adaptive randomized platform trial (vol 30, pg 3291, 2024)</atitle><jtitle>NATURE MEDICINE</jtitle><date>2024-08-28</date><risdate>2024</risdate><volume>30</volume><issue>11</issue><spage>3381</spage><pages>3381-</pages><issn>1078-8956</issn><doi>10.1038/s41591-024-03268-0</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1078-8956 |
| ispartof | NATURE MEDICINE, 2024-08, Vol.30 (11), p.3381 |
| issn | 1078-8956 |
| language | eng |
| recordid | cdi_swepub_primary_oai_swepub_ki_se_881503 |
| source | Springer Nature - Complete Springer Journals; Nature; SWEPUB Freely available online |
| title | Androgen receptor pathway inhibitors and taxanes in metastatic prostate cancer: an outcome-adaptive randomized platform trial (vol 30, pg 3291, 2024) |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T04%3A01%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-swepub&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Androgen%20receptor%20pathway%20inhibitors%20and%20taxanes%20in%20metastatic%20prostate%20cancer:%20an%20outcome-adaptive%20randomized%20platform%20trial%20(vol%2030,%20pg%203291,%202024)&rft.jtitle=NATURE%20MEDICINE&rft.au=De,%20Laere%20B&rft.date=2024-08-28&rft.volume=30&rft.issue=11&rft.spage=3381&rft.pages=3381-&rft.issn=1078-8956&rft_id=info:doi/10.1038/s41591-024-03268-0&rft_dat=%3Cswepub%3Eoai_swepub_ki_se_881503%3C/swepub%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |